Mode of death in heart failure: findings from the ATLAS trial (Q35580685)

9 August 2017

Mode of death in heart failure: findings from the ATLAS trial (English)

1 reference

9 August 2017

0 references

P A Poole-Wilson

1

1 reference

9 August 2017

B F Uretsky

2

1 reference

9 August 2017

K Thygesen

3

1 reference

9 August 2017

J G F Cleland

4

1 reference

9 August 2017

B M Massie

5

1 reference

9 August 2017

L Rydén

6

1 reference

9 August 2017

Atlas Study Group. Assessment of treatment with lisinopril and survival

7

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

9 August 2017

1 reference

9 August 2017

89

1 reference

9 August 2017

1

1 reference

9 August 2017

42-48

1 reference

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767481

Is the prognosis of heart failure improving?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767481

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767481

Survival of patients with a new diagnosis of heart failure: a population based study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767481

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767481

Interaction of ACE inhibitors and aspirin in patients with congestive heart failure

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767481

Statistical methods for dependent competing risks

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767481

Amiodarone therapy in chronic heart failure and myocardial infarction: a review of the mortality trials with special attention to STAT-CHF and the GESICA trials. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767481

Mode of death in chronic heart failure. A request and proposition for more accurate classification

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767481

The clinical course of heart failure and its modification by ACE inhibitors: insights from recent clinical trials

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767481

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767481

Clinical trials update: IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II, APRICOT and HEART.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767481

Risk stratification in chronic heart failure.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767481

The epidemiology of heart failure

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767481

Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767481

Ventilatory and heart rate responses to exercise : better predictors of heart failure mortality than peak oxygen consumption

26 September 2018

1 reference

12 December 2020

Predictors of medical events in patients enrolled in the Cardiac Insufficiency Bisoprolol Study (CIBIS): A study of the interactions between [beta ]-blocker therapy and occurrence of critical events using analysis of competitive risks

1 reference

12 December 2020

The aspirin-angiotensin-converting enzyme inhibitor tradeoff: to halve and halve not

1 reference

12 December 2020

Sudden death in heart failure: vascular or electrical?

1 reference

12 December 2020

Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study

1 reference

12 December 2020

Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial

1 reference

12 December 2020

Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial

1 reference

12 December 2020

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

1 reference

12 December 2020

A critical appraisal of the cardiac arrhythmia suppression trial (CAST)

1 reference

12 December 2020

Risk factors for early and late mortality in surgical treatment of coronary artery disease.

1 reference

12 December 2020

Interobserver discordance in the classification of mechanisms of death in studies of heart failure

1 reference

12 December 2020

Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease

1 reference

12 December 2020

Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart failure who are taking angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

In-hospital versus out-of-hospital presentation of life-threatening ventricular arrhythmias predicts survival: results from the AVID Registry. Antiarrhythmics Versus Implantable Defibrillators

1 reference

12 December 2020

Identifiers

DOI

10.1136/HEART.89.1.42

1 reference

9 August 2017

1 reference

9 August 2017

1 reference